| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |